These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24407179)

  • 1. The optimal timing of post-prostate biopsy magnetic resonance imaging to guide nerve-sparing surgery.
    Ko YH; Song PH; Moon KH; Jung HC; Cheon J; Sung DJ
    Asian J Androl; 2014; 16(2):280-4. PubMed ID: 24407179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
    Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
    BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
    Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve-sparing radical prostatectomy.
    Panebianco V; Salciccia S; Cattarino S; Minisola F; Gentilucci A; Alfarone A; Ricciuti GP; Marcantonio A; Lisi D; Gentile V; Passariello R; Sciarra A
    J Sex Med; 2012 Aug; 9(8):2157-66. PubMed ID: 22642466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging.
    Sharif-Afshar AR; Feng T; Koopman S; Nguyen C; Li Q; Shkolyar E; Saouaf R; Kim HL
    Can J Urol; 2015 Apr; 22(2):7698-702. PubMed ID: 25891332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accuracy of endorectal Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer].
    Baccos A; Schiavina R; Zukerman Z; Busato F; Gaudiano C; Salizzoni E; Fiorentino M; Golfieri R; Martorana G
    Urologia; 2012; 79(2):116-22. PubMed ID: 22522463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy.
    Kilic M; Vural M; Coskun B; Acar Ö; Saglican Y; Akpek S; Esen T
    Eur Urol Focus; 2020 Mar; 6(2):249-254. PubMed ID: 31054811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
    Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
    J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.
    Linder BJ; Kawashima A; Woodrum DA; Tollefson MK; Karnes J; Davis BJ; Rangel LJ; King BF; Mynderse LA
    Can J Urol; 2014 Jun; 21(3):7283-9. PubMed ID: 24978358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can preoperative prostate MRI before radical prostatectomy predict extracapsular extension and the side of the index lesion?].
    Albisinni S; De Groote A; Deneft F; Thoma P; Catteau X; Roumeguère T; Wildschutz T
    Prog Urol; 2016 Apr; 26(5):281-6. PubMed ID: 26996453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI.
    Pompe RS; Kühn-Thomä B; Nagaraj Y; Veleva V; Preisser F; Leyh-Bannurah SR; Graefen M; Huland H; Tilki D; Salomon G
    World J Urol; 2018 May; 36(5):705-712. PubMed ID: 29492583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results.
    Lee SH; Chung MS; Kim JH; Oh YT; Rha KH; Chung BH
    J Endourol; 2012 Jul; 26(7):787-91. PubMed ID: 22122555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
    Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
    Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer.
    Porpiglia F; Russo F; Manfredi M; Mele F; Fiori C; Regge D
    Int Braz J Urol; 2015; 41(1):124-33. PubMed ID: 25928518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How good is post-biopsy multiparametric magnetic resonance imaging in detecting and characterising the index lesion of localised prostate cancer?
    Engelhard K; Labanaris AP; Bogner K; Lübke L; Dworak O; Kühn R
    Scand J Urol; 2014 Dec; 48(6):499-505. PubMed ID: 24754780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.